1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Hyperactive Delirium: new trials by email Literature Review of Hyperactive Delirium trials Research Report on Hyperactive Delirium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care Dexmedetomidine Hydrochloride - Hyperactive Delirium, Delirium of Mixed Origin | Phase 1 / Phase 2 | Unknown | Bruyère Health Research Institute. | 50 | 2024-01-30 | 2025-04-15 |
Death (1) · Delirium (1) · Psychomotor Agitation (1)
Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Confusion (1) · Dyskinesias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Psychomotor Disorders (1) · Signs and Symptoms (1)
Dexmedetomidine (1)
Bruyère Health Research Institute. (1)
Canada (1)